Sandbox:Amd: Difference between revisions
Jump to navigation
Jump to search
(21 intermediate revisions by 2 users not shown) | |||
Line 7: | Line 7: | ||
<span style="font-size:85%">'''Abbreviations:''' | <span style="font-size:85%">'''Abbreviations: Na=''' Natrium/ Sodium, '''ADH= [[Antidiuretic hormone]]''' | ||
POLYURIA | POLYURIA<ref name="BhasinVelez2016">{{cite journal|last1=Bhasin|first1=Bhavna|last2=Velez|first2=Juan Carlos Q.|title=Evaluation of Polyuria: The Roles of Solute Loading and Water Diuresis|journal=American Journal of Kidney Diseases|volume=67|issue=3|year=2016|pages=507–511|issn=02726386|doi=10.1053/j.ajkd.2015.10.021}}</ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Mechanism | ! colspan="2" rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Mechanism | ||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Etiology | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Etiology | ||
! colspan=" | ! colspan="6" style="background:#4479BA; color: #FFFFFF;" |Clinical manifestations | ||
! colspan=" | ! colspan="5" style="background:#4479BA; color: #FFFFFF;" |Paraclinical findings | ||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Comments | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" |Comments | ||
|- | |- | ||
! colspan=" | ! colspan="6" style="background:#4479BA; color: #FFFFFF;" |Symptoms and signs | ||
! colspan=" | ! colspan="5" style="background:#4479BA; color: #FFFFFF;" |Lab findings/Urine exam | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Dysuria | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Nocturia | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Hesitancy | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Dribbling | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Hematuria | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Proteinuria | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Serum osmolarity | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |S. ADH | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" | | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Urine osmolarity | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Water deprivation test | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |ADH administration | |||
|- | |- | ||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Increased intake of fluid | ! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Increased intake of fluid | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Psychogenic polydipsia]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Psychogenic polydipsia]]<ref name="pmid6860053">{{cite journal| author=Mellinger RC, Zafar MS| title=Primary polydipsia. Syndrome of inappropriate thirst. | journal=Arch Intern Med | year= 1983 | volume= 143 | issue= 6 | pages= 1249-51 | pmid=6860053 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6860053 }}</ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Improves urine osmolarity | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No improvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased thirst | |||
|- | |- | ||
! rowspan=" | ! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Increased solute excretion | ||
! | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |Osmotic causes | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus]]<ref name="pmid104991902">{{cite journal| author=Ahloulay M, Schmitt F, Déchaux M, Bankir L| title=Vasopressin and urinary concentrating activity in diabetes mellitus. | journal=Diabetes Metab | year= 1999 | volume= 25 | issue= 3 | pages= 213-22 | pmid=10499190 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10499190 }}</ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Late stage | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |High in Type 2 | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hyperosmolar hyperglycemic state]] | |||
| style="padding: 5px 5px; background: # | |||
|- | |- | ||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Salt loss | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Salt loss | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diuretics]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diuretics]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Raised<ref name="pmid21468197">{{cite journal| author=Hwang KS, Kim GH| title=Thiazide-induced hyponatremia. | journal=Electrolyte Blood Press | year= 2010 | volume= 8 | issue= 1 | pages= 51-7 | pmid=21468197 | doi=10.5049/EBP.2010.8.1.51 | pmc=3041494 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21468197 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal, increased with thiazides<ref name="Loffing2004">{{cite journal|last1=Loffing|first1=J.|title=Paradoxical Antidiuretic Effect of Thiazides in Diabetes Insipidus: Another Piece in the Puzzle|journal=Journal of the American Society of Nephrology|volume=15|issue=11|year=2004|pages=2948–2950|issn=1046-6673|doi=10.1097/01.ASN.0000146568.82353.04}}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cerebral salt-wasting syndrome]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cerebral salt-wasting syndrome]]<ref name="pmid20066633">{{cite journal| author=Ozdemir H, Aycan Z, Degerliyurt A, Metin A| title=The treatment of cerebral salt wasting with fludrocortisone in a child with lissencephaly. | journal=Turk Neurosurg | year= 2010 | volume= 20 | issue= 1 | pages= 100-2 | pmid=20066633 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20066633 }}</ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Improves urine osmolarity | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No effect | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |- | ||
! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Impaired urinary concentration | ! rowspan="4" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Impaired urinary concentration | ||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Low ADH | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Low ADH | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Central diabetes insipidus]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Central diabetes insipidus]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No improvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Urine osmolarity improves | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Nephrogenic diabetes insipidus]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Nephrogenic diabetes insipidus]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Low | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No improvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |No improvement | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |- | ||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Renal disease | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Renal disease | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Renal tubular acidosis]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Renal tubular acidosis]]<ref name="pmid19721811">{{cite journal| author=Pereira PC, Miranda DM, Oliveira EA, Silva AC| title=Molecular pathophysiology of renal tubular acidosis. | journal=Curr Genomics | year= 2009 | volume= 10 | issue= 1 | pages= 51-9 | pmid=19721811 | doi=10.2174/138920209787581262 | pmc=2699831 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19721811 }}</ref> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |±<ref name="pmid29178965">{{cite journal| author=Ranawaka R, Dayasiri K, Gamage M| title=A child with distal (type 1) renal tubular acidosis presenting with progressive gross motor developmental regression and acute paralysis. | journal=BMC Res Notes | year= 2017 | volume= 10 | issue= 1 | pages= 618 | pmid=29178965 | doi=10.1186/s13104-017-2949-2 | pmc=5702097 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29178965 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Increased | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Bartter syndrome]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Bartter syndrome]] | ||
! | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Miscellaneous | |||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Benign Prostatic Hyperplasia (BPH)]]<ref name="pmid16379182">{{cite journal| author=Yoong HF, Sundaram MB, Aida Z| title=Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia. | journal=Med J Malaysia | year= 2005 | volume= 60 | issue= 3 | pages= 294-6 | pmid=16379182 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16379182 }}</ref> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |– | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |||
|- | |- | ||
|} | |} | ||
Line 961: | Line 941: | ||
|} | |} | ||
|} | |} | ||
==References== | |||
{{reflist|2}} |
Latest revision as of 21:45, 11 May 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Differential diagnosis
Abbreviations: Na= Natrium/ Sodium, ADH= Antidiuretic hormone
POLYURIA[1]
Mechanism | Etiology | Clinical manifestations | Paraclinical findings | Comments | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms and signs | Lab findings/Urine exam | |||||||||||||
Dysuria | Nocturia | Hesitancy | Dribbling | Hematuria | Proteinuria | Serum osmolarity | S. ADH | Urine osmolarity | Water deprivation test | ADH administration | ||||
Increased intake of fluid | Psychogenic polydipsia[2] | – | – | – | – | – | – | Normal | Normal | Low | Improves urine osmolarity | No improvement | Increased thirst | |
Increased solute excretion | Osmotic causes | Diabetes mellitus[3] | – | ± | – | – | – | Late stage | High in Type 2 | Normal | Normal | No effect | No effect | Hyperosmolar hyperglycemic state |
Salt loss | Diuretics | – | + | – | + | – | ± | Normal | Raised[4] | Normal, increased with thiazides[5] | No effect | No effect | ||
Cerebral salt-wasting syndrome[6] | – | – | – | – | – | – | Normal | Normal | Low | Improves urine osmolarity | No effect | |||
Impaired urinary concentration | Low ADH | Central diabetes insipidus | – | + | – | – | ± | ± | Increased | Low | Low | No improvement | Urine osmolarity improves | |
Nephrogenic diabetes insipidus | – | + | – | – | ± | ± | Increased | Normal | Low | No improvement | No improvement | |||
Renal disease | Renal tubular acidosis[7] | ± | ±[8] | – | – | ± | + | Increased | ||||||
Bartter syndrome | ||||||||||||||
Miscellaneous | Benign Prostatic Hyperplasia (BPH)[9] | + | + | + | + | ± | – | Normal |
Differential diagnosis
Abbreviations: AP= Anteroposterior, CXR= Chest X-ray, CT= Computed tomography, ABG= Arterial blood gas, V/Q= Ventilation/perfusion scan , EKG= Electrocardiogram, COPD= Chronic obstructive pulmonary disease, BNP= Brain natriuretic peptide, DVT= Deep vein thrombosis, HRCT= High Resolution CT, IgE= Immunoglobulin E
|
References
- ↑ Bhasin, Bhavna; Velez, Juan Carlos Q. (2016). "Evaluation of Polyuria: The Roles of Solute Loading and Water Diuresis". American Journal of Kidney Diseases. 67 (3): 507–511. doi:10.1053/j.ajkd.2015.10.021. ISSN 0272-6386.
- ↑ Mellinger RC, Zafar MS (1983). "Primary polydipsia. Syndrome of inappropriate thirst". Arch Intern Med. 143 (6): 1249–51. PMID 6860053.
- ↑ Ahloulay M, Schmitt F, Déchaux M, Bankir L (1999). "Vasopressin and urinary concentrating activity in diabetes mellitus". Diabetes Metab. 25 (3): 213–22. PMID 10499190.
- ↑ Hwang KS, Kim GH (2010). "Thiazide-induced hyponatremia". Electrolyte Blood Press. 8 (1): 51–7. doi:10.5049/EBP.2010.8.1.51. PMC 3041494. PMID 21468197.
- ↑ Loffing, J. (2004). "Paradoxical Antidiuretic Effect of Thiazides in Diabetes Insipidus: Another Piece in the Puzzle". Journal of the American Society of Nephrology. 15 (11): 2948–2950. doi:10.1097/01.ASN.0000146568.82353.04. ISSN 1046-6673.
- ↑ Ozdemir H, Aycan Z, Degerliyurt A, Metin A (2010). "The treatment of cerebral salt wasting with fludrocortisone in a child with lissencephaly". Turk Neurosurg. 20 (1): 100–2. PMID 20066633.
- ↑ Pereira PC, Miranda DM, Oliveira EA, Silva AC (2009). "Molecular pathophysiology of renal tubular acidosis". Curr Genomics. 10 (1): 51–9. doi:10.2174/138920209787581262. PMC 2699831. PMID 19721811.
- ↑ Ranawaka R, Dayasiri K, Gamage M (2017). "A child with distal (type 1) renal tubular acidosis presenting with progressive gross motor developmental regression and acute paralysis". BMC Res Notes. 10 (1): 618. doi:10.1186/s13104-017-2949-2. PMC 5702097. PMID 29178965.
- ↑ Yoong HF, Sundaram MB, Aida Z (2005). "Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia". Med J Malaysia. 60 (3): 294–6. PMID 16379182.
- ↑ Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.
- ↑ Khurshid I, Downie GH (2002). "Pulmonary arteriovenous malformation". Postgrad Med J. 78 (918): 191–7. PMC 1742331. PMID 11930021.
- ↑ Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G (2009). "Massive spontaneous hemothorax during the immediate postpartum period". Tex Heart Inst J. 36 (3): 247–9. PMC 2696501. PMID 19568398.
- ↑ Chanatry BJ (1992). "Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy". Anesth. Analg. 74 (4): 613–5. PMID 1554132.